PNEVANOL 23
23-valent pneumococcal polysaccharide vaccine
INDICATIONS
Prevention of pneumococcal infections in adults aged 50 years and older, as well as in children aged 2–18 years and adults at increased risk of pneumococcal infections.
AGE OF ADMINISTRATION
From 2 years of age.
VACCINATION SCHEDULE
A single 0.5 mL dose.
Revaccination is determined in accordance with current official immunization recommendations.
OFFICIAL DOCUMENTS
-
Summary of Product Characteristics for Pnevanol 23
Accessed: September 18, 2026.
-
State Register of Medicinal Products
Accessed: September 18, 2026.